HealthLeaders Media January 22, 2025
Healthcare executives are calling on the Trump Administration to nullify a DEA proposal to create a special registration for virtual prescribing of controlled drugs, saying the proposed rule ‘would be a major setback.’
KEY TAKEAWAYS
– After a 17-year delay, the DEA last week unveiled a proposal to create a special registration for providers wanting to prescribe controlled drugs via telemedicine.
– Telehealth advocates, who have long pressured the DEA and lawmakers to create that registration process, say the proposed rule is burdensome and overly complicated.
– They’re now calling on the Trump Administration to withdraw the proposed rule, with the hope that the DEA will work with advocates on a new version.
Healthcare executives who have lobbied the U.S....
Today's Sponsors
Today's Sponsor